Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
Additional Study Purpose Details: Phase I safety and pharmacokinetics study.
Detailed Description:
The study was terminated on 11/12/2008. There were no safety findings in this trial that resulted in the decision to terminate the trial. The study was closed in order to change the amount of drug that subjects would take and to shorten the number of days that the drug would be taken in a new study.
Age
65–85
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Healthy
Elderly
65-85
You may not be if
Evidence or history of clinically significant unstable disease
Clareo Health | A Phase I, Multiple Dose Study of PF-04447943 in Healthy Elderly Volunteers
